Qualitek Labs to Weigh Proposal for Issuing Non-Convertible Debentures

Qualitek Labs Ltd informed the stock exchanges that its board of directors is scheduled to meet shortly to deliberate on a proposal for the issuance of Non-Convertible Debentures (NCDs). The decision aligns with the company’s intent to explore diversified funding options for business growth and capital optimization.

NCDs are fixed-income instruments that allow companies to raise long-term funds without diluting equity. For Qualitek Labs, such an issuance could enhance liquidity, support working capital needs, and provide financing flexibility for upcoming projects or expansion initiatives.

The company is expected to disclose detailed terms—such as amount, tenure, interest rate, and mode of issuance—after board approval and regulatory compliance procedures are completed.

Key Highlights:

Board Meeting: To consider issuance of Non-Convertible Debentures (NCDs).

Objective: Strengthen financial resources and support business growth.

Expected Next Step: Detailed announcement post board deliberation.

Financial Move: Part of company’s broader capital optimization strategy.

Source: Company filing to BSE, December 17, 2025.